Cameron Javid, MD
Retina Specialist · Tucson, AZNPI 1518960632
Payments from drug & device makers
Across 322 payments — averaging $7161.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2M
- Janssen Research & Development, LLC$115K
- Novartis$87K
- ANI Pharmaceuticals, Inc.$64K
- Roche TCRC, Inc.$47K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $3K from 17 others
Across 14 payments — averaging $1968.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alimera Sciences, Inc.$28K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 114 | $1,989,092 |
| Janssen Research & Development, LLC | 28 | $115,475 |
| Novartis | 23 | $86,913 |
| ANI Pharmaceuticals, Inc. | 3 | $63,839 |
| Roche TCRC, Inc. | 7 | $46,759 |
| Regeneron Healthcare Solutions, Inc. | 48 | $1,230 |
| Genentech USA, Inc. | 28 | $717 |
| Astellas Pharma US Inc | 16 | $450 |
| Alimera Sciences, Inc. | 8 | $363 |
| Apellis Pharmaceuticals, Inc. | 11 | $309 |
| Rxsight Inc | 2 | $249 |
| AbbVie(2 entities) | 11 | $185 |
| Bausch & Lomb Americas Inc. | 6 | $136 |
| Coherus Oncology, Inc. | 3 | $84 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $57 |
| Eyepoint US, Inc. | 3 | $55 |
| Biogen | 2 | $35 |
| Carl Zeiss Meditec USA, Inc. | 1 | $25 |
| Spark Therapeutics, Inc. | 1 | $24 |
| Aerie Pharmaceuticals, Inc. | 1 | $24 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Dutch Ophthalmic, USA | 1 | $13 |
| Harrow Eye, LLC | 1 | $13 |
How this compares
$2,306,064 in reported general payments places this provider in the 90th percentile of 30 retina specialist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Tucson
- Anthony JosephTucson$122K
- George NovalisTucson$110K
- Mark WalshTucson$17K
- Diego CalonjeTucson$16K
- Igor KozakTucson$8K
- Ryan WongTucson$5K
- April HarrisTucson$4K
- Jane ChoTucson$2K
- Egbert SaavedraTucson$85
- Jordan GraffPhoenix$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.